Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Aussie success targets UK, US

Posted 15 September 2021 AM

Australian healthcare analytics company Prospection is expanding its presence in the US and UK after raising $45 million in its second external funding round.

CEO Eric Chung said the company is focused on making sure patients are on the right treatment and not being harmed.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Approvals Action
Melb pharma registers first copy
Long list of generic versions of PBS-listed drugs